Apyx Medical Corp
NASDAQ:APYX

Watchlist Manager
Apyx Medical Corp Logo
Apyx Medical Corp
NASDAQ:APYX
Watchlist
Price: 2.24 USD 0.45% Market Closed
Market Cap: 84.6m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one APYX stock under the Base Case scenario is hidden USD. Compared to the current market price of 2.24 USD, Apyx Medical Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

APYX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

1.8
P/S
P/S
Price to Sales
1.8
vs History
61
vs Industry
62
Median 3Y
1.6
Median 5Y
3.2
Industry
2.4
Forward
1.7
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-3.9
Median 5Y
-8.1
Industry
22.5
Forward
-6.1
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-5.7
Median 5Y
-10.5
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
37
Median 3Y
-4.7
Median 5Y
-11.6
Industry
20.4
More Details
8.1
P/B
P/B
Price to Book Value
8.1
vs History
6
vs Industry
23
Median 3Y
3.7
Median 5Y
3.9
Industry
2.2
More Details
1.9
EV/S
EV/S
Enterprise Value to Sales
1.9
vs History
60
vs Industry
63
Median 3Y
1.5
Median 5Y
2.9
Industry
2.6
Forward
1.8
More Details
3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3
vs History
55
vs Industry
71
Median 3Y
2.4
Median 5Y
4.3
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-5.4
Industry
11.9
Forward
-12.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-3.6
Median 5Y
-5.2
Industry
16.3
Forward
-8.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-5.5
Median 5Y
-8.9
Industry
14.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-5.3
Median 5Y
-8.3
Industry
17.9
More Details
3.3
EV/IC
EV/IC
Enterprise Value to IC
3.3
vs History
50
vs Industry
41
Median 3Y
2.2
Median 5Y
3.3
Industry
1.9
More Details

Multiples Across Competitors

APYX Competitors Multiples
Apyx Medical Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Apyx Medical Corp
NASDAQ:APYX
84.7m USD 1.8 -4.2 -6 -5.7
US
Abbott Laboratories
NYSE:ABT
228B USD 5.3 16.3 21.5 30.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
171.4B USD 18.7 65.7 51.1 61.5
US
Boston Scientific Corp
NYSE:BSX
151.9B USD 8.2 60.7 34.1 47
US
Stryker Corp
NYSE:SYK
143.9B USD 6 49.3 24.4 29.5
IE
Medtronic PLC
NYSE:MDT
118B USD 3.5 25.3 14.3 20.5
DE
Siemens Healthineers AG
XETRA:SHL
51.9B EUR 2.2 23.9 13.5 18.9
US
Becton Dickinson and Co
NYSE:BDX
55.9B USD 2.7 36.8 14.3 26.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
52.3B USD 12.9 53 38.2 42.3
US
Edwards Lifesciences Corp
NYSE:EW
45.1B USD 7.9 10.9 24 26.3
US
Resmed Inc
NYSE:RMD
41.5B USD 8.1 29.6 21.3 24.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Apyx Medical Corp
NASDAQ:APYX
Average EV/EBITDA: 25.7
Negative Multiple: -6 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
21.5
13%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
51.1
25%
2
US
Boston Scientific Corp
NYSE:BSX
34.1
22%
1.5
US
Stryker Corp
NYSE:SYK
24.4
12%
2
IE
Medtronic PLC
NYSE:MDT
14.3
7%
2
DE
Siemens Healthineers AG
XETRA:SHL
13.5
14%
1
US
Becton Dickinson and Co
NYSE:BDX
14.3
11%
1.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.2
12%
3.2
US
Edwards Lifesciences Corp
NYSE:EW
24
12%
2
US
Resmed Inc
NYSE:RMD
21.3
10%
2.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Apyx Medical Corp
NASDAQ:APYX
Average EV/EBIT: 32.7
Negative Multiple: -5.7 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
30.4
23%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
61.5
27%
2.3
US
Boston Scientific Corp
NYSE:BSX
47
33%
1.4
US
Stryker Corp
NYSE:SYK
29.5
16%
1.8
IE
Medtronic PLC
NYSE:MDT
20.5
16%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
18.9
19%
1
US
Becton Dickinson and Co
NYSE:BDX
26.7
27%
1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.3
13%
3.3
US
Edwards Lifesciences Corp
NYSE:EW
26.3
13%
2
US
Resmed Inc
NYSE:RMD
24.3
12%
2

See Also

Summary
APYX intrinsic value, competitors valuation, and company profile.
DCF Valuation
APYX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
APYX stock valuation using valuation multiples.
Wall Street Estimates
APYX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
APYX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 274,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.